文献速递免疫规划慢病防控与筛查

瑞士中轴型脊柱关节炎成人风险患者的肺炎球菌疫苗接种:来自瑞士强直性脊柱炎协会(SVMB)调查的数据

Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB).
PubMed 文献 · Vaccine · 2022-09-26

该研究基于瑞士强直性脊柱炎协会(SVMB)在线调查,评估接受生物制剂治疗的中轴型脊柱关节炎成人患者的肺炎球菌疫苗接种状况。1560名参与者中834名(53.5%)符合分析条件,疫苗覆盖率低至32.5%(271/834)。女性和每年接种流感疫苗者更可能接种,年龄与接种呈负相关;未接种者中64.1%(302/471)表示未被提供疫苗。

要点

  • 符合分析条件的834名患者中,肺炎球菌疫苗覆盖率为32.5%(271/834)。
  • 女性和每年接种流感疫苗者更可能接种,年龄与接种呈负相关。
  • 未接种者中64.1%(302/471)表示未被提供疫苗。

核心结论

  • 肺炎球菌疫苗覆盖率低,但若全科医生和专科医生系统性地提供疫苗,覆盖率可能提高。

研究设计与样本

  • 研究基于瑞士强直性脊柱炎协会(SVMB)开展的大型在线调查,1560名参与者中834名(53.5%)符合分析条件。

主要发现

  • 疫苗覆盖率为32.5%(271/834)。
  • 女性和每年接种流感疫苗的患者更可能接种,年龄与接种呈负相关。
  • 大多数接种者(54.2%;147/271)由全科医生接种。
  • 未接种者中64.1%(302/471)表示未被提供疫苗。

临床怎么用

  • 作者认为,若全科医生和专科医生系统性地提供疫苗,疫苗接种覆盖率可能提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While in Switzerland, pneumococcal vaccination is recommended for adult patients with axial spondyloarthritis (axSpA) treated with biological drugs, since 2014, little is known about the vaccination status of this specific patient population. This study assessed their vaccination status as part of a larger online survey by the ankylosing spondylitis association of Switzerland (SVMB). Out of 1560 who participated in the survey, 834 (53.5%) were eligible for the analysis. Vaccine coverage was low at 32.5% (271/834). Women and patients who got a flu shot every year were more likely to be covered. Age was negatively associated with being vaccinated. Most (54.2%; 147/271) were vaccinated by their general practitioner. Almost two-thirds of those who had not received the vaccine stated that it had not been offered to them (64.1%; 302/471). In summary, the vaccination coverage is low, but might be increased if the vaccine was offered systematically by general practitioners and specialists.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Stoffel ST, Colaninno A, Bräm R, et al. Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB). Vaccine. 2022. PMID: 36175212. doi:10.1016/j.vaccine.2022.09.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。